Effect of Ocimum basilicum in anxiety
Phase 2
Recruiting
- Conditions
- Depression, anxiety.Major depressive disorder, single episode
- Registration Number
- IRCT20230318057752N1
- Lead Sponsor
- Fasa University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Men and women between 18 and 65 years old
People with major depressive disorder based on DSM 5 criteria
Obtaining a minimum score of 18 in the Hamilton Anxiety Questionnaire
Not taking any new anti-anxiety medication in the last 1 month
Not suffering from significant internal diseases such as heart and lung failure, cancer, vascular disease, rheumatological disease, history of seizures and hypothyroidism, etc.
Not using anticoagulant or anti-platelet drugs such as warfarin, heparin, aspirin, etc.
No drug and alcohol addiction
Exclusion Criteria
Any allergy to Ocimum basilicum and its products
Pregnancy or breastfeeding
Hypersensitivity to specific serotonin re-uptake inhibitor drugs
Patients who will not have proper follow-up
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression score in Beck questionnaire. Timepoint: Before starting the study and 4 weeks after taking the drug. Method of measurement: Based on the Beck Depression Questionnaire.;Anxiety score in Hamilton questionnaire. Timepoint: Before starting the study and 4 weeks after taking the drug. Method of measurement: Based on Hamilton anxiety questionnaire.
- Secondary Outcome Measures
Name Time Method